Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

NCT01858766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

379

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: SOF
DRUG: VEL
DRUG: RBV

Sponsor

Gilead Sciences